A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?
Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT01009229
Collaborator
(none)
100
1
1
13
7.7
Study Details
Study Description
Brief Summary
Consecutive living-kidney donor candidates (n=100) will be recruited after being accepted for donation according to official guidelines. An assessment of salt sensitivity, 11 beta HSD activity, 24 hour blood pressure, urine collection and physical exam will be performed prior nephrectomy and 14, 52, 156, 208 days post-nephrectomy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Consecutive living-kidney donor candidates (n=100) will be recruited after being accepted for donation. The assessment of salt sensitivity, 11 beta HSD activity, 24 hour blood pressure, urine collection and physical exam will be performed prior nephrectomy and 14, 52, 156, 208 days post-nephrectomy.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Reduced 11 Beta Hydroxysteroid Dehydrogenase 2 (11 Beta HSD2) Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?
Study Start Date
:
Jun 1, 2009
Actual Primary Completion Date
:
Jul 1, 2010
Actual Study Completion Date
:
Jul 1, 2010
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: 1
|
Dietary Supplement: Low and high salt diets
High salt diet: 150mmol/d Low salt diet: 30mmol/d
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Salt sensitivity, arterial hypertension [day 0, 14, 52, 156, 208, yearly]
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- acceptance for living kidney donation
Exclusion Criteria:
- withdrawal of consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of nephrology and hypertension, Universitiy of Bern | Bern | Switzerland | 3010 |
Sponsors and Collaborators
- University Hospital Inselspital, Berne
Investigators
- Principal Investigator: Felix J Frey, Prof, University of Berne
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT01009229
Other Study ID Numbers:
- Uehlinger-001
First Posted:
Nov 6, 2009
Last Update Posted:
May 25, 2011
Last Verified:
May 1, 2011